Australia has officially joined the ranks of nations that have eliminated trachoma as a public health problem, marking the end of a decades-long battle against the world’s leading infectious cause of preventable blindness. The World Health Organization (WHO) declared the milestone on April 29, naming Australia the 30th country to achieve this status.
The achievement closes a stark health equity gap, as Australia was previously the only developed nation where trachoma remained endemic. The infection predominantly affected Aboriginal and Torres Strait Islander populations, driven by repeated bacterial infections resulting from poor sanitation and limited access to clean water in remote communities.
For medical professionals and public health advocates, the elimination of trachoma in Australia represents more than a clinical victory; We see the culmination of a movement that began nearly 50 years ago with a commitment to bringing world-class surgical care to the most isolated corners of the outback.
The journey toward this milestone was catalyzed in 1976 by Professor Fred Hollows, a visionary ophthalmologist who viewed the prevalence of blindness in Indigenous communities as a profound social injustice. Hollows, alongside the College of Ophthalmologists and the Commonwealth government, established the National Trachoma and Eye Health Program to provide free screenings and surgeries.
A Legacy of Outreach and Equity
In the program’s early years, medical teams traversed the continent to reach every Indigenous community. These missions were often rudimentary, with examinations conducted in old army tents or makeshift shelters. The effort was deeply collaborative, relying on liaison officers like Trevor “Buzza” Buzzacott, an Arabunna man, to build trust and communicate the program’s goals to local residents.
The scale of the initial effort was immense. Between 1976 and 1978, teams examined more than 60,000 Aboriginal people across roughly 400 communities, as well as nearly 40,000 other individuals in rural and remote areas. For many, the removal of post-operative eye pads marked the first time they had seen the world clearly in years, transforming lives through immediate surgical intervention.
However, early success in surgery alone was not enough to eradicate the disease. While surgery could treat the advanced stages of the infection—specifically the in-turned eyelashes that scar the cornea—it did not stop the cycle of reinfection among children.
The Shift to the SAFE Strategy
By 2008, the focus shifted toward a more holistic, community-driven approach. The establishment of the Indigenous Eye Health Unit allowed for the mobilization of resources aligned with the WHO SAFE strategy, a comprehensive public health framework designed to break the cycle of transmission.
The SAFE strategy employs four critical pillars to ensure long-term elimination:
- Surgery to correct trichiasis (in-turned eyelashes).
- Antibiotics to treat active infections in the community.
- Facial cleanliness to prevent the spread of the bacteria.
- Environmental improvements, such as increased access to water and sanitation.
The impact of this shift was measurable and profound. Trachoma prevalence among Indigenous children aged five to nine in at-risk communities plummeted from 14.9% in 2009 to just 1.5% in 2024.
| Metric | 2009 Status | 2024 Status |
|---|---|---|
| Prevalence (Children 5-9) | 14.9% | 1.5% |
| WHO Status | Endemic | Eliminated as public health problem |
| Primary Intervention | Surgical focus | Comprehensive SAFE strategy |
Community-Led Success and Global Implications
The final push toward elimination was driven largely by Aboriginal Community Controlled Health Organisations. By providing culturally safe care and fostering trust within communities, these organizations ensured that hygiene habits and environmental changes became sustainable.
The urgency of this work is underscored by the devastating systemic impact of vision loss. Data indicates that people who are blind are twice as likely to die and eight times more likely to suffer falls compared to those with good vision. In Australia, Aboriginal people continue to experience rates of blindness three times higher than the non-Indigenous population, making the eradication of trachoma a critical step in reducing overall mortality and morbidity.
WHO Director-General Dr. Tedros Adhanom Ghebreyesus noted that the success in Australia reflects a “sustained commitment” and a focus on reaching the populations most affected by health inequities.
This victory serves as a blueprint for other low- and middle-income regions where trachoma remains a threat. The translation of research from the lab to the community—a mission championed by the Fred Hollows Foundation and the Centre for Eye Research Australia—demonstrates that preventable blindness can be defeated through persistent, people-centric interventions and stable government funding.
Disclaimer: This article is for informational purposes only and does not constitute professional medical advice. Please consult a healthcare provider for medical concerns.
As Australia maintains its trachoma-free status, health authorities will now focus on sustaining these environmental and hygiene gains to prevent any resurgence of the bacteria. The next phase of national eye health will likely prioritize addressing the remaining disparities in blindness rates between Indigenous and non-Indigenous populations.
We invite you to share your thoughts on this public health milestone in the comments below or share this story with your network.
